280 related articles for article (PubMed ID: 12634234)
1. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies.
Sthoeger ZM; Zinger H; Mozes E
Ann Rheum Dis; 2003 Apr; 62(4):341-6. PubMed ID: 12634234
[TBL] [Abstract][Full Text] [Related]
2. Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody.
Eilat E; Zinger H; Nyska A; Mozes E
J Clin Immunol; 2000 Jul; 20(4):268-78. PubMed ID: 10939714
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations.
Dayan M; Zinger H; Kalush F; Mor G; Amir-Zaltzman Y; Kohen F; Sthoeger Z; Mozes E
Immunology; 1997 Jan; 90(1):101-8. PubMed ID: 9038719
[TBL] [Abstract][Full Text] [Related]
4. The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus.
Sthoeger ZM; Bentwich Z; Zinger H; Mozes E
J Rheumatol; 1994 Dec; 21(12):2231-8. PubMed ID: 7699622
[TBL] [Abstract][Full Text] [Related]
5. Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment.
Ramos-Barrón A; Piñera-Haces C; Gómez-Alamillo C; Santiuste-Torcida I; Ruiz JC; Buelta-Carrillo L; Merino R; de Francisco AL; Arias M
Lupus; 2007; 16(10):775-81. PubMed ID: 17895299
[TBL] [Abstract][Full Text] [Related]
6. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
[TBL] [Abstract][Full Text] [Related]
7. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
9. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice.
Lacotte S; Dumortier H; Décossas M; Briand JP; Muller S
J Immunol; 2010 Apr; 184(7):3937-45. PubMed ID: 20181885
[TBL] [Abstract][Full Text] [Related]
10. Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice.
Yamauchi T; Ishibashi A; Shikata K; Tokuhara N; Seino K; Kobayashi S; Nagai M
J Pharmacol Exp Ther; 2005 Mar; 312(3):938-44. PubMed ID: 15615868
[TBL] [Abstract][Full Text] [Related]
11. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
[TBL] [Abstract][Full Text] [Related]
14. Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.
Ramos MA; Piñera C; Setién MA; Buelta L; de Cos MA; de Francisco AL; Merino R; Arias M
Nephrol Dial Transplant; 2003 May; 18(5):878-83. PubMed ID: 12686658
[TBL] [Abstract][Full Text] [Related]
15. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
Liu Z; Bethunaickan R; Huang W; Lodhi U; Solano I; Madaio MP; Davidson A
Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
[TBL] [Abstract][Full Text] [Related]
16. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
[TBL] [Abstract][Full Text] [Related]
18. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice.
Fredriksen K; Osei A; Sundsfjord A; Traavik T; Rekvig OP
Eur J Immunol; 1994 Jan; 24(1):66-70. PubMed ID: 8020573
[TBL] [Abstract][Full Text] [Related]
19. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
20. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]